HFA Premium Access

A preliminary evaluation of a novel lifestyle intervention in patients with hypertrophic cardiomyopathy

Congress Presentation

About the speaker

Doctor Amy Fuller

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)
0 follower

34 more presentations in this session

Prospective evaluation of left heart echocardiographic parameters of the EMPAG-HF patient cohort(effects of empagliflozin on diuresis and renal function in patients with acute decompensated HF)

Speaker: Mr J. Bogoviku (Jena, DE)

Thumbnail

Pharmacological inhibition of Hippo pathway with XMU-MP-1 does not improve outcomes in mice with autoimmune myocarditis.

Speaker: Doctor M. Nieto (Valladolid, ES)

Thumbnail

T cell and antibody response following double dose of BNT162b2 mRNA Vaccine in heart transplant recipients

Speaker: Doctor M. Vanderheyden (Aalst, BE)

Thumbnail

Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure.

Speaker: Doctor A. Mazza (Orvieto, IT)

Thumbnail

Recovery of left ventricular dysfunction after sacubitril/valsartan administration in patients with Duchenne muscular distrophy and advanced heart failure

Speaker: Doctor A. Arcudi (Rome, IT)

Thumbnail

Access the full session

Heart Failure ePosters - focus on Chronic Heart Failure 6

Speakers: Doctor A. Fuller, Mr J. Bogoviku, Doctor M. Nieto, Doctor M. Vanderheyden, Doctor A. Mazza...
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb